Immunopathogenesis of experimental ulcerative colitis is mediated by eosinophil peroxidase

被引:128
作者
Forbes, E
Murase, T
Yang, M
Matthaei, KI
Lee, JJ
Lee, NA
Foster, PS
Hogan, SP [1 ]
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Allergy & Inflammat Res Grp, Canberra, ACT 0200, Australia
[2] Mayo Clin, Scottsdale, AZ 85259 USA
关键词
D O I
10.4049/jimmunol.172.9.5664
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The precise role that individual inflammatory cells and mediators play in the development of gastrointestinal (GI) dysfunction and extraintestinal clinical manifestations of ulcerative colitis (UC) is unknown. In this study, we have used a mouse model of UC to establish a central role for eotaxin and, in turn, eosinophils in the development of the immunopathogenesis of this disease. In this model the administration of dextran sodium sulfate (DSS) induces a prominent colonic eosinophilic inflammation and GI dysfunction (diarrhea with blood and, shortening of the colon) that resembles UC in patients. GI dysfunction was associated with evidence of eosinophilic cytolytic degranulation and the release of eosinophil peroxidase (EPO) into the colon lumen. By using IL-5 or eotaxin-deficient mice, we show an important role for eotaxin in eosinophil recruitment into the colon during experimental UC. Furthermore, using EPO-deficient mice and an EPO inhibitor resorcinol we demonstrate that eosinophil-derived peroxidase is critical in the development of GI dysfunction in experimental UC. These findings provide direct evidence of a central role for eosinophils and EPO in GI dysfunction and potentially the immunopathogenesis of UC.
引用
收藏
页码:5664 / 5675
页数:12
相关论文
共 60 条
[1]   Immunohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease [J].
Bischoff, SC ;
Mayer, J ;
Nguyen, QT ;
Stolte, M ;
Manns, MP .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (12) :3521-3529
[2]   Animal models of mucosal inflammation and their relation to human inflammatory bowel disease [J].
Blumberg, RS ;
Saubermann, LJ ;
Strober, W .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (06) :648-656
[3]   Insights from mouse models of colitis [J].
Boismenu, R ;
Chen, YP .
JOURNAL OF LEUKOCYTE BIOLOGY, 2000, 67 (03) :267-278
[4]  
Carlson M, 1999, AM J GASTROENTEROL, V94, P1876
[5]   Human neutrophil lipocalin is a unique marker of neutrophil inflammation in ulcerative colitis and proctitis [J].
Carlson, M ;
Raab, Y ;
Sevéus, L ;
Xu, S ;
Hällgren, R ;
Venge, P .
GUT, 2002, 50 (04) :501-506
[6]   Increased serum levels of eotaxin in patients with inflammatory bowel disease [J].
Chen, W ;
Paulus, B ;
Shu, D ;
Wilson, I ;
Chadwick, V .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2001, 36 (05) :515-520
[7]   Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration [J].
Cheng, JF ;
Ott, NL ;
Peterson, EA ;
George, TJ ;
Hukee, MJ ;
Gleich, GJ ;
Leiferman, KM .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (05) :683-692
[8]   Eosinophil major basic protein-1 does not contribute to allergen-induced airway pathologies in mouse models of asthma [J].
Denzler, KL ;
Farmer, SC ;
Crosby, JR ;
Borchers, M ;
Cieslewicz, G ;
Larson, KA ;
Cormier-Regard, S ;
Lee, NA ;
Lee, JJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (10) :5509-5517
[9]   Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation [J].
Denzler, KL ;
Borchers, MT ;
Crosby, JR ;
Cieslewicz, G ;
Hines, EM ;
Justice, JP ;
Cormier, SA ;
Lindenberger, KA ;
Song, W ;
Wu, WJ ;
Hazen, SL ;
Gleich, GJ ;
Lee, JJ ;
Lee, NA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1672-1682
[10]   MECHANISM-BASED INACTIVATION OF LACTOPEROXIDASE AND THYROID PEROXIDASE BY RESORCINOL DERIVATIVES [J].
DIVI, RL ;
DOERGE, DR .
BIOCHEMISTRY, 1994, 33 (32) :9668-9674